Recent Blog Posts

View Post: Orphan drug designation granted to voreloxin for acute myeloid ...
5 Nov 2009
Celsion Corporation announced initiation of a nationwide enrollment program in its Phase 1/2 trial for the use of ThermoDox (liposomal intravenous doxorubicin) for the treatment of recurrent chest wall (RCW) breast cancer. ... Johnson) announced that it received a complete response letter from the FDA regarding the New Drug Application (NDA) for trabectedin in combination with Doxil (doxorubicin HCI liposome injection) for the treatment of relapsed ovarian cancer. ...
View Blog: Latest articles from MPR News - http://www.empr.com/

---

View Post: FDA Approves Millennium Pharmaceuticals, Inc. (Cambridge ...
23 Jun 2008
... with previously treated multiple myeloma (N=1008, not including the Phase III, VELCADE plus DOXIL® [doxorubicin HCl liposome injection] study) and previously treated mantle cell lymphoma (N=155) were integrated and tabulated. ...
View Blog: BioSpace.com Featured News and Stories - http://www.biospace.com/

---

View Post: What's New from the Office of Oncology Drug Products*
FDA ...
6 Nov 2009 ...
View Blog: http://www.healthcare-packaging.com/

---

View Post: Centocor Ortho Biotech Receives FDA Complete Response Letter ...
11 Sep 2009
... Administration (FDA) regarding its Supplemental New Drug Application (sNDA) for DOXIL (doxorubicin HCI liposome injection)in combination with docetaxel for the treatment of women with locally advanced and metastatic breast cancer. ...
View Blog: Johnson & Johnson-All News - http://www.jnj.com/connect/news/all/

---

View Post: Orphan drugs
30 Oct 2009 by ToufiqS  
... porcine (poractact alfa) Doxorubicin HCL liposome injection Calfactant Trade Name Alphanate Curosurf Disease Von Willebrand disease Respiratory distress syndrome in premature infants Multiple myeloma Respiratory failure in preterm ...
View Blog: Docstoc feed for: Medicine - http://www.docstoc.com/documents/medicine/most-recent/

---

View Post: In Clinical Trials VELCADE (Bortezomib) for Injection as a ...
1 Jun 2009
Lenalidomide, Bortezomib, pegylated liposomal doxorubicin hydrochloride, and dexamethasone in newly diagnosed multiple myeloma: Initial results of the Phase I/II Multiple Myeloma Research Consortium Trial ...
View Blog: Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html

---

View Post: Targeted Nanomedicines in Onchotherapy
Pharmainfo.net
31 Oct 2009 by komal nikam   ...
View Blog: http://www.pharmainfo.net/

---

View Post: (JNJ) FDA Delays Johnson & Johnson's Cancer Drug
Stock Blog Hub
11 Sep 2009 by vitalstocks   ...
View Blog: http://www.stockbloghub.com/

---